← Leaderboards
John H Groffen
Children'S Hospital Los Angeles
$5,609,057
Attributed
$6,849,077
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $742.6K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$6,849,077 · 5
By mechanism
R01$3,959,298 · 3
P01$2,889,779 · 2
Top collaborators
- Nora C Heisterkamp9 shared
Most similar at Children'S Hospital Los Angeles
Same institution · by research overlap
- Nora C Heisterkamp$7,613,746
- Parviz Minoo Minoo$21,236,245
- Prasadarao V Nemani$5,799,150
- David Warburton$16,806,840
- Rik M. Derynck$18,375,653
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsPathway InteractionsSignal TransductionCellsResearch StudyLeadIn VitroGlycolipidsMediatingDrug ResistanceLaboratory MouseLocationLectinRelapseCell SurfaceCell SurvivalCancer TypeApoptoticBronchopulmonary DysplasiaExtracellularLeukemiaExcisionPre-B Acute Lymphoblastic LeukemiaStromal Cells
Grant awards (23)
Microenvironment-Leukemia Communication Through Lectins$89,230
R01 · FY2017 · CA
Microenvironment-Leukemia Communication Through Lectins$336,150
R01 · FY2016 · CA
Role of Sialic Acid Modification in ALL Survival and Drug Resistance$266,069
R01 · FY2016 · CA
Microenvironment-Leukemia Communication Through Lectins$336,150
R01 · FY2015 · CA
Role of Sialic Acid Modification in ALL Survival and Drug Resistance$266,069
R01 · FY2015 · CA
Microenvironment-Leukemia Communication Through Lectins$326,066
R01 · FY2014 · CA
Role of Sialic Acid Modification in ALL Survival and Drug Resistance$258,087
R01 · FY2014 · CA
Microenvironment-Leukemia Communication Through Lectins$336,150
R01 · FY2013 · CA
Role of Sialic Acid Modification in ALL Survival and Drug Resistance$266,069
R01 · FY2013 · CA
Negative Regulation of Lung Inflammation by ABR/BCR$316,557
P01 · FY2009 · HL · contact PI
Negative Regulation of Lung Inflammation by ABR/BCR$435,693
P01 · FY2008 · HL · contact PI
Negative Regulation of Lung Inflammation by ABR/BCR$420,523
P01 · FY2007 · HL · contact PI
Negative Regulation of Lung Inflammation by ABR/BCR$370,266
P01 · FY2006 · HL · contact PI
NEGATIVE REGULATORS OF LUNG INFLAMMATION$363,258
R01 · FY2006 · HL · contact PI
NEGATIVE REGULATORS OF LUNG INFLAMMATION$372,000
R01 · FY2005 · HL
Negative Regulation of Lung Inflammation by ABR/BCR$370,634
P01 · FY2005 · HL
NEGATIVE REGULATORS OF LUNG INFLAMMATION$372,000
R01 · FY2004 · HL
NEGATIVE REGULATORS OF LUNG INFLAMMATION$372,000
R01 · FY2003 · HL
TGF BETA3 IN LUNG MORPHOGENESIS, INJURY AND REPAIR$187,536
P01 · FY2002 · HL
TGF BETA3 IN LUNG MORPHOGENESIS, INJURY AND REPAIR$187,536
P01 · FY2002 · HL
TGF BETA3 IN LUNG MORPHOGENESIS, INJURY AND REPAIR$187,536
P01 · FY2001 · HL
TGF BETA3 IN LUNG MORPHOGENESIS, INJURY AND REPAIR$225,962
P01 · FY2000 · HL
TGF BETA3 IN LUNG MORPHOGENESIS, INJURY AND REPAIR$187,536
P01 · FY2000 · HL